Home Online Features Historic achievement: FDA approval of Abeona Therapeutics' ZEVASKYN accelerates momentum and expands treatment options for the EB community.
Historic achievement: FDA approval of Abeona Therapeutics’ ZEVASKYN accelerates momentum and expands treatment options for the EB community.
Press Releases
April 29, 2025

Historic achievement: FDA approval of Abeona Therapeutics’ ZEVASKYN accelerates momentum and expands treatment options for the EB community.

By EB Research Partnership

EB Research Partnership ("EBRP") invested in the work that led to ZEVASKYN at Stanford University under their pioneering Venture Philanthropy Model. This approval marks a historic moment for the EB

bradford

The Bradford Era

email
Local & Social